8 Despite of the numerous studies about the presence of podoplanin expression in various oral tissues and tumours, little is known about its physiologic or pathologic function. Sawa et al.15 suggested an association of podoplanin in cellular proliferative activity due to its expression in tooth germ, which is present in cells with high mitotic activity, i.e. in dental lamina, terminal portion of Hertwig sheath and pre-ameloblasts. Tsuneki et al. 13 selleck products found that podoplanin-positive cells are located within areas with PCNA-positive cells in ameloblastomas, keratocystic odontogenic tumours, adenomatoid odontogenic tumours, and calcifying cystic odontogenic tumours. 13 On the other hand, a previous study conducted

by our research group has showed absence of significant correlation between podoplanin and epithelial odontogenic proliferative activity in ameloblastomas reinforcing that the exact role of this protein buy Erlotinib in the benign odontogenic tumours needs to be elucidated. 14 In view of the above considerations, the aim of this study was to investigate the expression of podoplanin in two groups of odontogenic tumours: those exclusively composed by epithelial neoplastic components and

those composed by epithelial and ectomesenchymal tumoral cells. Additionally, we verified the possible association between podoplanin immunoexpression and the proliferative activity in keratocystic odontogenic tumours and orthokeratinized odontogenic cysts. Fifty-four odontogenic tumours were selected from the archives of the Laboratory of Pathology, Bauru School of Dentistry

– University of São Paulo, Brazil, for the current study: Odontogenic epithelium without ectomesenchyme: • 8 ameloblastomas (AM): 4 follicular and 4 plexiform subtypes; Odontogenic epithelium with ectomesencyhme: • 2 ameloblastic fibromas (AF); The tumours were stained with haematoxylin–eosin and reviewed according to the World Health Organization histological Methocarbamol classification of odontogenic tumours.16 This study was approved by the Research Ethics Committee of the Bauru School of Dentistry, University of São Paulo (process number 99/2010). A formalin-fixed 4-μm section of epithelial odontogenic tumours was taken from the pathology archive for immunohistochemistry analysis of anti-podoplanin and anti-Ki-67 antibodies expressions by odontogenic cells. Only KCOTS and OOC were submitted to the Ki-67 antibody reaction. After antigen retrieval using 10 mM citrate buffer, pH 6.0, in a domestic pressure cooker (Nigro, model Eterna 4(1/2) L, Brazil) for 4 min, endogenous peroxidase activity was blocked by incubation in 3% H2O2 for 20 min. Each epithelial odontogenic tumour section was incubated overnight at 4 °C with the primary monoclonal anti-podoplanin antibody (D2-40 clone, code#3619-1; Dako North America, Inc., Carpinteria, CA, USA), dilution 1:200 or anti-Ki-67 antibody (MIB-1 clone, Dako North America, Inc.